BB&T Securities’s Repligen RGEN Stock Holding History

BB&T Securities’s Portfolio RGEN Stock Details RGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-4,409	Closed	-$378K	–	1677
2019 Q2	$378K	Buy	+4,409	New	+$301K	﹤0.01%	1220

Other funds holding RGEN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

FAM

Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

1WCM

12 West Capital Management New York $535M AUM 25.99% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

BB&T Securities's RGEN Position: Q3 2019 in Review

BB&T Securities sold out of Repligen (RGEN) in Q3 2019, closing a stake of 4,409 shares — an estimated $378K sold.

BB&T Securities first reported a position in RGEN in Q2 2019 and held it in 1 quarter. The position peaked at $378K in Q2 2019. 303 funds tracked by Wall St. Rank hold RGEN as of Q3 2019.

BB&T Securities reported no remaining Repligen position as of Q3 2019 after selling out during the quarter.
BB&T Securities sold 4,409 Repligen shares in Q3 2019, an estimated $378K.
BB&T Securities first reported a position in Repligen in Q2 2019 and held it in 1 quarter.
BB&T Securities's Repligen position peaked at $378K in Q2 2019.
303 funds tracked by Wall St. Rank held Repligen as of Q3 2019.

Based on BB&T Securities's 13F filing for Q3 2019, filed 30 Oct 2019.